{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34265238",
  "DateCompleted": {
    "Year": "2021",
    "Month": "08",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "11",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "07",
        "Day": "12"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/S2213-2600(21)00328-3",
      "S2213-2600(21)00328-3"
    ],
    "Journal": {
      "ISSN": "2213-2619",
      "JournalIssue": {
        "Volume": "9",
        "Issue": "8",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug"
        }
      },
      "Title": "The Lancet. Respiratory medicine",
      "ISOAbbreviation": "Lancet Respir Med"
    },
    "ArticleTitle": "Lifting of COVID-19 restrictions in the UK and the Delta variant.",
    "Pagination": {
      "StartPage": "e85",
      "MedlinePgn": "e85"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Burki",
        "ForeName": "Talha Khan",
        "Initials": "TK"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Lancet Respir Med",
    "NlmUniqueID": "101605555",
    "ISSNLinking": "2213-2600"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Basic Reproduction Number"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "transmission",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "methods",
        "trends"
      ],
      "DescriptorName": "Communicable Disease Control"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Diagnostic Self Evaluation"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Disease Transmission, Infectious"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Health Services Needs and Demand"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunity, Herd"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Patient Education as Topic"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Symptom Assessment"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "United Kingdom"
    }
  ]
}